#section-16-5137 > .ct-section-inner-wrap{padding-top:10px;padding-right:10px;padding-bottom:10px;padding-left:10px}#div_block-17-5137{width:100%;position:relative;display:flex;flex-direction:column;max-height:500px;height:422px;margin-bottom:30px}#div_block-19-5137{display:flex;height:100%;flex-direction:column}#headline-20-5137{z-index:20;color:#ffffff;line-height:1;font-size:3rem;text-shadow:3px 3px 3px #1a1e21}@media (max-width:479px){#headline-20-5137{font-size:2rem}}#_rich_text-21-5137{font-family:'Montserrat';margin-bottom:5px;font-weight:400}#image-18-5137{background-image:linear-gradient(rgba(76,175,217,0.4),rgba(76,175,217,0.4)),url(https://tribeclinicalresearch.com/wp-content/uploads/2026/03/Tribe-Clinical-Research™-and-Greenville-ENT-Allergy-Announce-Partnership-to-Expand-Access-to-Clinical-Trials.jpg);background-size:auto,cover;z-index:1;position:absolute;width:100%;height:100%;object-fit:cover;object-position:50% 50%}